申请人:New York University
公开号:US20180170910A1
公开(公告)日:2018-06-21
The invention relates to compounds and pharmaceutical compositions capable of treating amyloid diseases and other diseases characterized by oligomerization and/or fibrillation of amyloidogenic peptides such as amyloid beta peptide (Abeta or Aβ).
该发明涉及能够治疗淀粉样病和其他以淀粉样蛋白质寡聚化和/或纤维化为特征的疾病的化合物和药物组合物,如淀粉样β肽(Abeta或Aβ)。